0001855756--12-312023Q2false2023-06-3000018557562023-01-012023-06-300001855756ifrs-full:LaterThanOneYearMember2023-06-300001855756ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2023-06-300001855756ifrs-full:LaterThanFiveYearsMember2023-06-300001855756ifrs-full:LaterThanOneYearMember2022-12-310001855756ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2022-12-310001855756ifrs-full:LaterThanFiveYearsMember2022-12-310001855756lilm:ClassCSharesMember2023-02-012023-02-280001855756lilm:ClassBSharesMember2023-02-012023-02-280001855756lilm:ClassaSharesMember2023-02-012023-02-2800018557562022-11-012022-11-3000018557562022-11-300001855756lilm:AcevillePte.LimitedMemberifrs-full:MajorOrdinaryShareTransactionsMember2023-07-012023-08-310001855756lilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2022-11-300001855756lilm:ClassaSharesMemberlilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2023-01-012023-06-300001855756lilm:ClassaSharesMemberlilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2022-11-012022-11-300001855756lilm:ClassaSharesMemberlilm:ExecutiveBonusesMember2023-06-300001855756lilm:EquitySettledOptionsMember2023-01-012023-06-300001855756lilm:CashSettledOptionsMember2023-01-012023-06-300001855756lilm:AdditionalFundingAmountPrefundedMemberlilm:May2023WarrantsMember2023-07-012023-07-310001855756lilm:AcevillePte.LimitedMemberlilm:AdditionalFundingAmountPrefundedMember2023-07-012023-07-310001855756lilm:May2023WarrantsMember2023-05-012023-05-310001855756lilm:WarrantsMemberlilm:May2023WarrantsMember2023-01-012023-06-300001855756lilm:ClassCSharesMemberifrs-full:MajorOrdinaryShareTransactionsMember2023-09-132023-09-130001855756lilm:ClassCSharesMemberifrs-full:MajorOrdinaryShareTransactionsMember2023-07-072023-07-070001855756lilm:CashSettledOptionsMemberlilm:ExecutivesJointStockOwnershipPlanJsopMember2022-12-012022-12-310001855756lilm:CashSettledOptionsMemberlilm:ExecutivesJointStockOwnershipPlanJsopMember2022-12-310001855756lilm:IfrsGeneralAndAdministrativeExpenseMemberlilm:ShadowBonusMember2023-01-012023-06-300001855756lilm:IfrsGeneralAndAdministrativeExpenseMemberlilm:JointStockOwnershipPlanMember2023-01-012023-06-300001855756lilm:ClassaSharesMember2023-01-012023-06-300001855756lilm:ClassCSharesMember2023-02-280001855756lilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMember2023-07-012023-07-310001855756lilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMemberlilm:PublicOffering2023Member2023-07-012023-07-310001855756lilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMemberlilm:IfrsPrivatePlacementMember2023-07-012023-07-310001855756lilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMemberlilm:IfrsOverAllotmentOptionMember2023-07-012023-07-310001855756lilm:ShareholdersMemberlilm:ClassaSharesMemberlilm:CloudSubscriptionMember2023-01-012023-06-300001855756lilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMemberlilm:PublicOffering2023Member2023-07-310001855756lilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMemberlilm:IfrsOverAllotmentOptionMember2023-07-310001855756lilm:RegisteredDirectOfferingWarrantsMember2023-06-300001855756lilm:PublicWarrantsMember2023-06-300001855756lilm:PrivateWarrantsMember2023-06-300001855756lilm:PrivateInvestmentInPublicEquityWarrantsMember2023-06-300001855756lilm:RegisteredDirectOfferingWarrantsMember2022-12-310001855756lilm:PublicWarrantsMember2022-12-310001855756lilm:PrivateWarrantsMember2022-12-310001855756lilm:PrivateInvestmentInPublicEquityWarrantsMember2022-12-310001855756lilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMemberlilm:IfrsPrivatePlacementMember2023-07-310001855756lilm:WarrantsMemberlilm:AnnualConditionalProbabilitiesOfAdditionalFundingAmountMeasurementInputMember2023-06-300001855756lilm:ClassaSharesMember2022-01-012022-06-300001855756lilm:ExecutivesJointStockOwnershipPlanJsopAndShadowBonusMember2023-01-012023-06-300001855756lilm:ClassCSharesMember2023-01-012023-06-300001855756lilm:ClassBSharesMember2023-01-012023-06-300001855756lilm:ClassaSharesMemberlilm:May2023WarrantsMember2023-05-3100018557562022-01-012022-12-310001855756lilm:ShareholdersMemberlilm:CloudSubscriptionMember2023-10-310001855756lilm:ShareholdersMemberlilm:CloudSubscriptionMember2023-06-300001855756lilm:ExpectedTermMeasurementInputMemberlilm:Rdo2022PipeWarrantsMember2023-06-300001855756lilm:ExpectedTermMeasurementInputMemberlilm:May2023WarrantsMember2023-06-300001855756ifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberlilm:Rdo2022PipeWarrantsMember2023-06-300001855756ifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberlilm:May2023WarrantsMember2023-06-300001855756lilm:DividendRateMeasurementInputMember2023-06-300001855756ifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberlilm:Rdo2022PipeWarrantsMember2022-12-310001855756lilm:ZenlabsEnergyIncMember2023-01-012023-06-300001855756lilm:TestingComponentAndMaterialCostsMember2023-01-012023-06-300001855756lilm:IonbloxIncMember2023-01-012023-06-300001855756lilm:CertificationAndSerialProductionMember2023-01-012023-06-300001855756lilm:AmortizationAndDepreciationExpensesMember2023-01-012023-06-300001855756lilm:TestingComponentAndMaterialCostsMember2022-01-012022-06-300001855756lilm:IonbloxIncMember2022-01-012022-06-300001855756lilm:CertificationAndSerialProductionMember2022-01-012022-06-300001855756lilm:AmortizationAndDepreciationExpensesMember2022-01-012022-06-300001855756ifrs-full:TreasurySharesMember2023-01-012023-06-300001855756ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2022-01-012022-06-300001855756lilm:StichtingJsopMember2023-01-012023-06-300001855756lilm:LiliumSchweizGmbhMember2023-01-012023-06-300001855756lilm:LiliumGmbhMember2023-01-012023-06-300001855756lilm:LiliumEaircraftGmbhMember2023-01-012023-06-300001855756lilm:LiliumAviationUkLtdMember2023-01-012023-06-300001855756lilm:LiliumAviationSpainSlMember2023-01-012023-06-300001855756lilm:LiliumAviationIncMember2023-01-012023-06-300001855756lilm:StichtingJsopMember2022-01-012022-06-300001855756lilm:LiliumSchweizGmbhMember2022-01-012022-06-300001855756lilm:LiliumGmbhMember2022-01-012022-06-300001855756lilm:LiliumEaircraftGmbhMember2022-01-012022-06-300001855756lilm:LiliumAviationUkLtdMember2022-01-012022-06-300001855756lilm:LiliumAviationSpainSlMember2022-01-012022-06-300001855756lilm:LiliumAviationIncMember2022-01-012022-06-300001855756lilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMemberlilm:May2023WarrantsMember2023-07-012023-08-310001855756lilm:AcevillePte.LimitedMemberlilm:ClassaSharesMemberifrs-full:MajorOrdinaryShareTransactionsMember2023-07-012023-08-310001855756lilm:WarrantsMemberlilm:AnnualConditionalProbabilitiesOfAdditionalFundingAmountMeasurementInputMemberlilm:May2023WarrantsMember2023-06-300001855756ifrs-full:Level3OfFairValueHierarchyMemberlilm:SharePriceMeasurementInputMember2023-06-300001855756ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMember2023-06-300001855756lilm:SharePriceMeasurementInputMemberlilm:May2023WarrantsMember2023-05-310001855756lilm:AnnualConditionalProbabilitiesOfAdditionalFundingAmountMeasurementInputMemberlilm:May2023WarrantsMember2023-05-310001855756ifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberlilm:May2023WarrantsMember2023-05-310001855756ifrs-full:Level3OfFairValueHierarchyMemberlilm:SharePriceMeasurementInputMember2022-12-310001855756ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMember2022-12-310001855756lilm:ClassCSharesMemberifrs-full:TopOfRangeMember2023-05-250001855756lilm:ClassCSharesMemberifrs-full:BottomOfRangeMember2023-05-250001855756lilm:ClassBSharesMemberifrs-full:TopOfRangeMember2023-05-250001855756lilm:ClassBSharesMemberifrs-full:BottomOfRangeMember2023-05-250001855756lilm:ClassaSharesMemberifrs-full:TopOfRangeMember2023-05-250001855756lilm:ClassaSharesMemberifrs-full:BottomOfRangeMember2023-05-250001855756lilm:ShareholdersMemberlilm:CloudSubscriptionMember2021-12-310001855756lilm:ClassCSharesMember2023-06-300001855756lilm:ClassBSharesMember2023-06-300001855756lilm:ClassaSharesMember2023-06-300001855756lilm:ClassCSharesMember2022-12-310001855756lilm:ClassBSharesMember2022-12-310001855756lilm:ClassaSharesMember2022-12-310001855756lilm:ClassBSharesMember2022-06-300001855756lilm:ClassaSharesMember2022-06-300001855756lilm:ClassBSharesMember2021-12-310001855756lilm:ClassaSharesMember2021-12-310001855756lilm:CashSettledOptionsMemberlilm:ExecutivesJointStockOwnershipPlanJsopMember2023-01-012023-06-300001855756lilm:EquitySettledOptionsMemberlilm:StandardEmployeeStockOptionProgramMember2023-01-012023-06-300001855756lilm:EquitySettledOptionsMemberlilm:StandardEmployeeStockOptionProgramMember2022-01-012022-06-300001855756lilm:StandardEmployeeStockOptionProgramMember2023-06-300001855756lilm:StandardEmployeeStockOptionProgramMember2022-06-300001855756lilm:EquitySettledOptionsMemberlilm:StandardEmployeeStockOptionProgramMember2023-06-300001855756lilm:CashSettledOptionsMemberlilm:StandardEmployeeStockOptionProgramMember2023-06-300001855756lilm:GeneralPopulationRestrictedStockUnitsRsuMember2023-06-300001855756lilm:ExecutivesTimeBasedStockOptionsMember2023-06-300001855756lilm:ExecutivesRestrictedStockUnitsRsuMember2023-06-300001855756lilm:ExecutivesPerformanceBasedStockOptionsMember2023-06-300001855756lilm:ExecutivesEsopModifiedMember2023-06-300001855756ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2023-06-300001855756lilm:EquitySettledOptionsMemberlilm:StandardEmployeeStockOptionProgramMember2022-12-310001855756lilm:GeneralPopulationRestrictedStockUnitsRsuMember2022-12-310001855756lilm:ExecutivesTimeBasedStockOptionsMember2022-12-310001855756lilm:ExecutivesRestrictedStockUnitsRsuMember2022-12-310001855756lilm:ExecutivesPerformanceBasedStockOptionsMember2022-12-310001855756lilm:ExecutivesEsopModifiedMember2022-12-310001855756lilm:EquitySettledOptionsMemberlilm:StandardEmployeeStockOptionProgramMember2022-06-300001855756lilm:CashSettledOptionsMemberlilm:StandardEmployeeStockOptionProgramMember2022-06-300001855756lilm:GeneralPopulationRestrictedStockUnitsRsuMember2022-06-300001855756lilm:ExecutivesTimeBasedStockOptionsMember2022-06-300001855756lilm:ExecutivesRestrictedStockUnitsRsuMember2022-06-300001855756lilm:ExecutivesPerformanceBasedStockOptionsMember2022-06-300001855756lilm:ExecutivesEsopModifiedMember2022-06-300001855756lilm:EquitySettledOptionsMemberlilm:StandardEmployeeStockOptionProgramMember2021-12-310001855756lilm:GeneralPopulationRestrictedStockUnitsRsuMember2021-12-310001855756lilm:ExecutivesTimeBasedStockOptionsMember2021-12-310001855756lilm:ExecutivesRestrictedStockUnitsRsuMember2021-12-310001855756lilm:ExecutivesPerformanceBasedStockOptionsMember2021-12-310001855756lilm:ExecutivesEsopModifiedMember2021-12-310001855756lilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2023-06-300001855756lilm:ExecutiveBonusesMember2023-06-300001855756lilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2022-06-300001855756lilm:Rdo2022PipeWarrantsMemberifrs-full:Level3OfFairValueHierarchyMember2023-06-300001855756lilm:May2023WarrantsMemberifrs-full:Level3OfFairValueHierarchyMember2023-06-300001855756lilm:Rdo2022PipeWarrantsMemberifrs-full:Level3OfFairValueHierarchyMember2022-12-310001855756lilm:ZenlabsEnergyIncMember2023-06-300001855756lilm:ZenlabsEnergyIncMember2022-12-310001855756ifrs-full:CapitalReserveMemberlilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2022-11-012022-11-300001855756lilm:ClassBSharesMemberifrs-full:TreasurySharesMember2023-01-012023-06-300001855756lilm:ClassBSharesMemberifrs-full:SharePremiumMember2023-01-012023-06-300001855756ifrs-full:IssuedCapitalMember2023-01-012023-06-300001855756ifrs-full:CapitalReserveMember2023-01-012023-06-300001855756ifrs-full:SharePremiumMember2022-01-012022-06-300001855756ifrs-full:IssuedCapitalMember2022-01-012022-06-300001855756ifrs-full:CapitalReserveMember2022-01-012022-06-300001855756ifrs-full:Level3OfFairValueHierarchyMemberlilm:SharePriceMeasurementInputMember2023-01-012023-06-300001855756ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMember2023-01-012023-06-300001855756ifrs-full:Level3OfFairValueHierarchyMemberlilm:SharePriceMeasurementInputMember2022-01-012022-12-310001855756ifrs-full:Level3OfFairValueHierarchyMemberifrs-full:HistoricalVolatilityForSharesMeasurementInputMember2022-01-012022-12-310001855756lilm:SharePriceMeasurementInputMemberlilm:May2023WarrantsMember2023-05-012023-05-310001855756ifrs-full:HistoricalVolatilityForSharesMeasurementInputMemberlilm:May2023WarrantsMember2023-05-012023-05-310001855756lilm:ShareholdersMemberlilm:CloudSubscriptionMember2023-01-012023-06-300001855756lilm:SuccessFeeMember2023-01-012023-06-300001855756lilm:PersonnelExpensesMember2023-01-012023-06-300001855756lilm:OtherMiscellaneousExpensesMember2023-01-012023-06-300001855756lilm:ItCostsMember2023-01-012023-06-300001855756lilm:DirectorAndOfficersLiabilityInsuranceMember2023-01-012023-06-300001855756lilm:ContractorAndConsultingExpensesMember2023-01-012023-06-300001855756lilm:CloudSubscriptionMember2023-01-012023-06-300001855756lilm:ShareholdersMemberlilm:CloudSubscriptionMember2022-01-012022-06-300001855756lilm:SuccessFeeMember2022-01-012022-06-300001855756lilm:PersonnelExpensesMember2022-01-012022-06-300001855756lilm:OtherMiscellaneousExpensesMember2022-01-012022-06-300001855756lilm:ItCostsMember2022-01-012022-06-300001855756lilm:DirectorAndOfficersLiabilityInsuranceMember2022-01-012022-06-300001855756lilm:ContractorAndConsultingExpensesMember2022-01-012022-06-300001855756lilm:Rdo2022PipeWarrantsMemberifrs-full:Level3OfFairValueHierarchyMember2023-01-012023-06-300001855756lilm:May2023WarrantsMemberifrs-full:Level3OfFairValueHierarchyMember2023-01-012023-06-300001855756ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberlilm:WarrantsMemberifrs-full:Level3OfFairValueHierarchyMember2023-06-300001855756ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberlilm:WarrantsMemberifrs-full:Level2OfFairValueHierarchyMember2023-06-300001855756ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberlilm:WarrantsMemberifrs-full:Level1OfFairValueHierarchyMember2023-06-300001855756ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberlilm:TradeAndOtherPayablesNonCurrentMember2023-06-300001855756ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberlilm:TradeAndOtherPayablesCurrentMember2023-06-300001855756ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberlilm:NoncurrentOtherLiabilitiesMember2023-06-300001855756ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberlilm:CurrentOtherFinancialLiabilitiesMember2023-06-300001855756ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberlilm:WarrantsMemberifrs-full:Level3OfFairValueHierarchyMember2022-12-310001855756ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberlilm:WarrantsMemberifrs-full:Level2OfFairValueHierarchyMember2022-12-310001855756ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberlilm:WarrantsMemberifrs-full:Level1OfFairValueHierarchyMember2022-12-310001855756ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberlilm:TradeAndOtherPayablesNonCurrentMember2022-12-310001855756ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberlilm:TradeAndOtherPayablesCurrentMember2022-12-310001855756ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberlilm:NoncurrentOtherLiabilitiesMember2022-12-310001855756ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberlilm:CurrentOtherFinancialLiabilitiesMember2022-12-310001855756ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberlilm:SecurityDepositsMember2023-06-300001855756ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberlilm:NoncurrentSecurityDepositsMember2023-06-300001855756ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberlilm:IfrsCashAndCashEquivalentsMember2023-06-300001855756ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberlilm:FixedTermDepositMember2023-06-300001855756ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberlilm:SecurityDepositsMember2022-12-310001855756ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberlilm:NoncurrentSecurityDepositsMember2022-12-310001855756ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberlilm:IfrsCashAndCashEquivalentsMember2022-12-310001855756ifrs-full:FinancialAssetsAtAmortisedCostCategoryMemberlilm:FixedTermDepositMember2022-12-310001855756ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2023-01-012023-06-300001855756lilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2023-01-012023-06-300001855756lilm:ShareBasedPaymentMember2023-01-012023-06-300001855756lilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2022-11-012022-11-300001855756lilm:EquitySettledOptionsMemberlilm:ShareBasedPaymentVendorsMember2022-01-012022-06-300001855756lilm:ExecutivesTimeBasedStockOptionsMember2022-01-012022-06-300001855756lilm:ExecutivesSuccessFeesCashSettledMember2022-01-012022-06-300001855756lilm:ExecutivesShadowBonusMember2022-01-012022-06-300001855756lilm:ExecutivesJointStockOwnershipPlanJsopMember2022-01-012022-06-300001855756lilm:ExecutivesJointStockOwnershipPlanJsopAndShadowBonusMember2022-01-012022-06-300001855756lilm:StandardEmployeeStockOptionProgramMember2022-01-012022-06-300001855756lilm:GeneralPopulationRestrictedStockUnitsRsuMember2022-01-012022-06-300001855756lilm:ExecutivesRestrictedStockUnitsRsuMember2022-01-012022-06-300001855756lilm:ExecutivesPerformanceBasedStockOptionsMember2022-01-012022-06-300001855756lilm:ExecutivesEsopModifiedMember2022-01-012022-06-300001855756lilm:RetainedEarningsAccumulatedLossMember2023-06-300001855756ifrs-full:TreasurySharesMember2023-06-300001855756ifrs-full:SharePremiumMember2023-06-300001855756ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2023-06-300001855756ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-06-300001855756ifrs-full:IssuedCapitalMember2023-06-300001855756ifrs-full:CapitalReserveMember2023-06-300001855756lilm:RetainedEarningsAccumulatedLossMember2022-12-310001855756ifrs-full:TreasurySharesMember2022-12-310001855756ifrs-full:SharePremiumMember2022-12-310001855756ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2022-12-310001855756ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-12-310001855756ifrs-full:IssuedCapitalMember2022-12-310001855756ifrs-full:CapitalReserveMember2022-12-310001855756lilm:RetainedEarningsAccumulatedLossMember2022-06-300001855756ifrs-full:TreasurySharesMember2022-06-300001855756ifrs-full:SharePremiumMember2022-06-300001855756ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2022-06-300001855756ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-06-300001855756ifrs-full:IssuedCapitalMember2022-06-300001855756ifrs-full:CapitalReserveMember2022-06-300001855756lilm:RetainedEarningsAccumulatedLossMember2021-12-310001855756ifrs-full:TreasurySharesMember2021-12-310001855756ifrs-full:SharePremiumMember2021-12-310001855756ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2021-12-310001855756ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-12-310001855756ifrs-full:IssuedCapitalMember2021-12-310001855756ifrs-full:CapitalReserveMember2021-12-310001855756lilm:StandardEmployeeStockOptionProgramMember2023-01-012023-06-300001855756lilm:GeneralPopulationRestrictedStockUnitsRsuMember2023-01-012023-06-300001855756lilm:ExecutivesRestrictedStockUnitsRsuMember2023-01-012023-06-300001855756lilm:ExecutivesEsopModifiedMember2023-01-012023-06-300001855756lilm:ExecutivesTimeBasedStockOptionsMember2023-01-012023-06-300001855756lilm:ExecutivesPerformanceBasedStockOptionsMember2023-01-012023-06-300001855756ifrs-full:TopOfRangeMemberlilm:ExecutivesTimeBasedStockOptionsMember2023-01-012023-06-300001855756ifrs-full:TopOfRangeMemberlilm:ExecutivesPerformanceBasedStockOptionsMember2023-01-012023-06-300001855756ifrs-full:BottomOfRangeMemberlilm:ExecutivesPerformanceBasedStockOptionsMember2023-01-012023-06-300001855756ifrs-full:BottomOfRangeMemberlilm:ExecutivesTimeBasedStockOptionsMember2022-01-012022-06-300001855756lilm:May2023WarrantsMember2023-05-310001855756lilm:AcevillePte.LimitedMember2023-05-310001855756lilm:ReorganizationWarrantsMember2023-06-300001855756lilm:Rdo2022PipeWarrantsMember2023-06-300001855756lilm:May2023WarrantsMember2023-06-300001855756lilm:ReorganizationWarrantsMember2022-12-310001855756lilm:Rdo2022PipeWarrantsMember2022-12-310001855756ifrs-full:PropertyPlantAndEquipmentMember2023-06-300001855756ifrs-full:IntangibleAssetsOtherThanGoodwillMember2023-06-300001855756ifrs-full:PropertyPlantAndEquipmentMember2022-12-310001855756ifrs-full:IntangibleAssetsOtherThanGoodwillMember2022-12-310001855756lilm:RetainedEarningsAccumulatedLossMember2023-01-012023-06-300001855756ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2023-01-012023-06-300001855756ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-01-012023-06-300001855756lilm:RetainedEarningsAccumulatedLossMember2022-01-012022-06-300001855756ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2022-01-012022-06-300001855756ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-01-012022-06-300001855756ifrs-full:TreasurySharesMemberifrs-full:MajorOrdinaryShareTransactionsMember2023-08-012023-08-010001855756ifrs-full:SharePremiumMemberifrs-full:MajorOrdinaryShareTransactionsMember2023-08-012023-08-010001855756ifrs-full:IssuedCapitalMemberifrs-full:MajorOrdinaryShareTransactionsMember2023-08-012023-08-0100018557562022-06-3000018557562021-12-310001855756lilm:CloudSubscriptionMember2023-06-300001855756lilm:CloudSubscriptionMember2022-12-3100018557562022-01-012022-06-3000018557562023-06-3000018557562022-12-31lilm:trancheiso4217:EURiso4217:EURxbrli:sharesxbrli:purelilm:Yiso4217:USDlilm:Optionsxbrli:sharesiso4217:USDxbrli:shareslilm:item

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of September, 2023.

Commission File Number 001-40736

Lilium N.V.

(Translation of registrant’s name into English)

Claude Dornier Straße 1

Bldg. 335, 82234

Wessling, Germany

Telephone: +49 160 9704 6857

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F Form 40-F

CONTENTS

Explanatory Note

On September 15, 2023, Lilium N.V. (the “Company”) issued (i) its Unaudited Condensed Interim Financial Statements as of and for the six months ended June 30, 2023 and (ii) its Management’s Discussion & Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2023, which are furnished as Exhibits 99.1 and 99.2 to this Report on Form 6-K, respectively.

Incorporation by Reference

The contents of this Report on Form 6-K, including Exhibits 99.1 and 99.2, are hereby incorporated by reference into the Company’s registration statements on Form F-3 filed with the U.S. Securities and Exchange Commission (“SEC”) on June 9, 2023 (File No. 333-272571), February 3, 2023 (File No. 333-269568), November 25, 2022, as amended or supplemented (File No. 333-268562), and October 3, 2022, as amended or supplemented (File Nos. 333-267718 and 333-267719), and the Company’s registration statement on Form S-8 filed with the SEC on November 18, 2021 (File No. 333-261175).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: September 15, 2023

Lilium N.V.

 

 

By:

/s/ Klaus Roewe

 

Name: Klaus Roewe

 

Title:   Chief Executive Officer and Executive Director

EXHIBIT INDEX

Exhibit Number

    

Description of Document

99.1

Unaudited Condensed Interim Financial Statements of Lilium N.V. as of and for the six months ended June 30, 2023

99.2

Management’s Discussion & Analysis of Financial Condition and Results of Operations of Lilium N.V. for the six months ended June 30, 2023

0.890.430000000

Table of Contents

Exhibit 99.1

Graphic

INTERIM CONDENSED

CONSOLIDATED FINANCIAL STATEMENTS

As of and for the six month period ended June 30, 2023

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Interim Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) for the six month periods ended June 30, 2023 and 2022

in € thousand

    

Note

    

June 30, 2023

    

June 30, 2022

Research and development expenses

 

[5]

 

(84,295)

 

(83,028)

General and administrative expenses

 

[6]

 

(40,192)

 

(46,987)

Selling expenses

 

[7]

 

(4,252)

 

(9,574)

Other income

 

1,435

 

2,599

Other expenses

 

(1,222)

 

(1,393)

Operating loss

 

(128,526)

 

(138,383)

Finance income

 

[8]

 

3,021

 

16,597

Finance expenses

 

[8]

 

(258,739)

 

(931)

Financial result

 

[8]

 

(255,718)

 

15,666

Share of loss in a joint venture

 

[11]

 

(1,165)

 

(1,457)

Loss before income tax

 

(385,409)

 

(124,174)

Income tax (expense) / benefits

 

[9]

 

(83)

 

478

Net loss for the period

 

(385,492)

 

(123,696)

Other comprehensive income / (loss)

in € thousand (except per share data)

    

Note

    

June 30, 2023

    

June 30, 2022

Other comprehensive income / (loss) that may be reclassified to profit or loss

 

45

 

(5)

Exchange differences on translation of foreign business units

 

45

 

(5)

Items that will not be subsequently reclassified to profit or loss

 

10

 

(68)

Remeasurement of defined pension benefit obligation

 

10

 

(68)

Other comprehensive income / (loss)

 

55

 

(73)

Total consolidated comprehensive loss for the period

 

(385,437)

 

(123,769)

Loss per share (basic and diluted) in €

 

(0.89)

 

(0.43)

The accompanying notes are an integral part of these interim condensed consolidated financial statements (IFRS).

1

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Interim Condensed Consolidated Statement of Financial Position as of June 30, 2023 and December 31, 2022

in € thousand

    

Note

    

06/30/2023

    

12/31/2022

ASSETS

Intangible assets

 

692

 

870

Property, plant and equipment

 

[10]

44,856

 

36,699

Investment in a joint venture

 

[11]

12,245

 

13,410

Other financial assets

[12]

3,451

 

3,386

Non-financial assets

 

[13]

17,188

 

13,487

Non-current assets

78,432

 

67,852

Other financial assets

 

[12]

60,203

 

22,581

Non-financial assets

 

[13]

9,883

 

18,648

Income tax receivable

107

169

Cash and cash equivalents

120,387

 

179,581

Current assets

190,580

 

220,979

Total Assets

269,012

 

288,831

SHAREHOLDERS’ (DEFICIT) / EQUITY AND LIABILITIES

Subscribed capital

 

[14]

54,196

 

53,104

Share premium

[14]

843,158

 

843,074

Other capital reserves

 

[14]

373,765

 

277,654

Treasury shares

[14]

(185)

 

(279)

Accumulated loss

(1,355,690)

 

(970,198)

Accumulated other comprehensive income

203

 

148

Shareholders’ (deficit) / equity

(84,553)

 

203,503

Other financial liabilities

 

[16]

19

 

21

Lease liabilities

9,110

 

8,353

Provisions

452

 

445

Trade and other payables

1,850

 

3,483

Deferred tax liabilities

 

10

Non-current liabilities

11,431

 

12,312

Other financial liabilities

 

[16]

1,004

 

4

Lease liabilities

3,007

 

2,616

Share-based payment liability

[15]

43

 

1,046

Provisions

699

 

730

Income tax payable

260

 

128

Warrants

 

[17]

292,044

 

26,267

Trade and other payables

38,225

 

33,658

Other non-financial liabilities

6,852

 

8,567

Current liabilities

342,134

 

73,016

Total Shareholders’ (Deficit) / Equity and Liabilities

269,012

 

288,831

The accompanying notes are an integral part of these interim condensed consolidated financial statements (IFRS).

2

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Interim Condensed Consolidated Statement of Changes in Shareholders’ Equity for the six month periods ended June 30, 2023 and 2022

    

    

    

    

    

    

    

Accumulated other  

    

comprehensive income

    

Remeasurement

of defined

Other

Currency

pension

Subscribed

Share

capital

Treasury

Accumulated

translation

benefit

in € thousand

Note

    

 capital

    

 premium

    

reserves

    

 shares

    

 loss

    

reserve  

    

obligation

    

Total  

January 1, 2022

40,138

779,141

240,430

(151)

(717,134)

83

4

342,511

Loss for the period

(123,696)

 

(123,696)

Other comprehensive loss

(5)

 

(68)

(73)

Total comprehensive loss

(123,696)

(5)

 

(68)

(123,769)

Share-based payment awards

[15]

12,836

 

12,836

Conversion share-based payment awards into shares

[15]

1,007

206

(990)

 

223

Share capital increase - ELOC

[14]

32

664

696

June 30, 2022

41,177

779,347

252,940

(151)

(840,830)

78

 

(64)

232,497

January 1, 2023

53,104

843,074

277,654

(279)

(970,198)

116

 

32

203,503

Loss for the period

(385,492)

 

(385,492)

Other comprehensive income

45

 

10

55

Total comprehensive (loss)/income

(385,492)

45

 

10

(385,437)

Share-based payment awards

[15]

14,399

 

14,399

Conversion share-based payment awards into shares

[15]

1,270

(1,117)

 

153

Conversion of Class B shares

[14]

84

(84)

Cancellation of issued shares

[14]

(178)

178

Contribution from shareholder

[17]

82,829

82,829

June 30, 2023

54,196

843,158

373,765

(185)

(1,355,690)

161

 

42

(84,553)

The accompanying notes are an integral part of these interim condensed consolidated financial statements (IFRS).

3

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Interim Condensed Consolidated Statement of Cash Flows for the six month periods ended June 30, 2023 and 2022

in € thousand

    

June 30, 2023

    

June 30, 2022

Net loss for the period

 

(385,492)

 

(123,696)

Adjustments to reconcile consolidated net loss to net cash flows:

 

 

Income tax expense/(benefits)

 

83

 

(478)

Net interest

 

(1,106)

 

654

Depreciation, amortization and impairment

 

4,854

 

3,743

Expenses for share-based payments

 

14,517

 

12,272

Share of loss in a joint venture

 

1,165

 

1,457

Fair value changes of financial instruments and expected credit losses (ECL)

 

256,824

 

(16,320)

Income taxes paid

 

100

 

(39)

Change in provisions

 

(12)

 

1,475

Working capital adjustments:

 

 

Changes in trade and other payables

 

5,279

 

1,028

Changes in other assets and liabilities

 

1,766

 

(2,817)

Cash flow from operating activities

 

(102,022)

 

(122,721)

Purchases of intangible assets

 

(26)

 

(103)

Purchases of and advance payments on property, plant and equipment

 

(8,238)

 

(2,169)

Disposals of intangible assets, property, plant and equipment

 

 

9

Proceeds from short-term investments

 

20,000

 

179,823

Payments for short-term investments

 

(60,000)

 

(80,000)

Interest paid

 

 

(121)

Interest received

 

1,275

 

Cash flow from investing activities

 

(46,989)

 

97,439

Proceeds from issue of May 2023 Warrants

 

91,811

 

Proceeds from share capital increase and capital contribution

 

153

 

255

Principal elements of lease payments

 

(1,813)

 

(1,315)

Interest paid

 

(348)

 

(417)

Cash flow from financing activities

 

89,803

 

(1,477)

Cash-based changes in cash and cash equivalents

 

(59,208)

 

(26,759)

Effect of foreign exchange rate changes on cash and cash equivalents

 

(33)

 

35

Effect of change in expected credit loss provisions

47

Net decrease in cash and cash equivalents

 

(59,194)

 

(26,724)

Cash and cash equivalents at the beginning of the period

 

179,581

 

129,856

Cash and cash equivalents at the end of the period

 

120,387

 

103,132

The accompanying notes are an integral part of these interim condensed consolidated financial statements (IFRS).

4

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Table of Contents

1.

Corporate Information

6

2.

Basis of Preparation and Changes to the Group’s Accounting Policies

6

3.

Significant Accounting Judgments, Estimates and Assumptions

8

4.

Covid-19 Risks and Uncertainties, War in Ukraine and Geopolitical Conflicts

8

5.

Research and Development Expenses

8

6.

General and Administrative Expenses

9

7.

Selling Expenses

9

8.

Financial Result

9

9.

Income Taxes

9

10.

Property, Plant and Equipment

10

11.

Investment in a Joint Venture

10

12.

Other Financial Assets

10

13.

Non-Financial Assets

11

14.

Shareholders’ (deficit) / equity

11

15.

Share-based Payments

13

16.

Other Financial Liabilities

19

17.

Warrants

19

18.

Additional Disclosures on Financial Instruments

21

19.

Commitments and Contingencies

24

20.

Related Party Disclosures

24

21.

Events after the Reporting Period

26

5

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1.Corporate Information

Lilium N.V. (“the Company”), together with its consolidated entities (“Lilium” or the “Group”), is a technology company in the field of urban air mobility and intends to make regional air mobility a reality. Since its founding, Lilium has primarily engaged in research and development of a proprietary electric Vertical Takeoff and Landing (eVTOL) jet (the “Lilium Jet”) for production and operation of a regional air mobility service as well as related services.

Lilium N.V. is a public company under Dutch law and is registered under the Dutch trade register number 82165874. Lilium N.V. has its activities exclusively in Germany. The registered headquarters is Claude-Dornier Str. 1, Geb. 335, 82234 Wessling, Germany. The Company is publicly listed and traded on Nasdaq under the symbols “LILM” for its Class A ordinary shares (“Class A shares”) and “LILMW” for its listed redeemable warrants (“Public Warrants”) since September 15, 2021.

The interim condensed consolidated financial statements of the Group, for the six month period ended June 30, 2023, were authorized for issue by the Company’s Board of Directors (“the Board”) on September 13, 2023.

2.Basis of Preparation and Changes to the Group’s Accounting Policies

The Group’s interim condensed consolidated financial statements for the six month periods ended June 30, 2023 and 2022 are prepared in accordance with IAS 34 Interim Financial Reporting.

The interim condensed consolidated financial statements have been prepared on a going concern basis, applying a historical cost convention, unless otherwise indicated. They are prepared and reported in thousands of Euro (“€ thousand”) except where otherwise stated. Due to rounding, numbers presented may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Group’s audited annual consolidated financial statements as of December 31, 2022.

Consolidated entities are as follows:

    

    

    

equity interest

 

owned in %

Country of

Date of

June 30, 

June 30, 

 

Name

Incorporation

incorporation

2022

2023

Lilium N.V.

 

Netherlands

March 11, 2021

 

n/a

n/a

Lilium GmbH

 

Germany

February 11, 2015

 

100.0

%  

100.0

%

Lilium Schweiz GmbH

 

Switzerland

December 8, 2017

 

100.0

%  

100.0

%

Lilium Aviation UK Ltd.

 

United Kingdom

December 20, 2017

 

100.0

%  

100.0

%

Lilium Aviation Inc.

 

United States

July 1, 2020

 

100.0

%  

100.0

%

Lilium eAircraft GmbH

 

Germany

August 17, 2020

 

100.0

%  

100.0

%

Stichting JSOP

 

Netherlands

September 10, 2021

 

0.0

%  

0.0

%

Lilium Aviation Spain SLU

 

Spain

April 7, 2022

 

100.0

%  

100.0

%

Going Concern

The financial statements have been prepared on a basis that assumes the Group will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business. Management assessed the Group’s ability to continue as a going concern and evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Group’s ability to continue as a going concern using all information available about the future, focusing on the twelve-month period after the issuance date of the financial statements.

6

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Historically, the Group has funded its operations primarily through capital raises and loans from shareholders. Since its inception, the Group has incurred recurring losses and negative cash flows from operations (accumulated losses of €1,355.7 million as of June 30, 2023). The Group expects to continue generating operating losses and negative cash flow from operations for several years. At the reporting date, the Group has a shareholders’ deficit of €84,553 thousand, which is mainly driven by the operational losses carried forward by the Group and the fair value movement of the warrants as disclosed in note 17. The going concern basis is driven by the Group’s available liquidity and its ability to settle its liabilities and commitments. The warrants are settled upon exercise by warrant holders via issuance of Class A Shares against the applicable exercise price without negatively impacting the liquidity of the Group.

Lilium’s financing plan shows substantial financing needs for several years. Based on its business plan, the Group depends on additional financing for development activities and operations which is currently not assured.

The Group’s current forecast indicates that the Group does not have sufficient funds to fund its operations for several years. Additionally, the Group must reach several milestones, including completion of its research and development program, and obtaining regulatory approvals, which will have an increased importance as the Group progresses towards commercialization. Consequently, the Group’s ability to continue as a going concern is largely dependent on its ability to successfully progress with its business model and to secure additional funds in the near future through a combination of debt financings, equity offerings, partnerships and grant funding. The Group plans to secure additional capital in the next 12 months and beyond through, for example, equity offerings, grants, debt financing, or collection of pre-delivery payments (“PDPs”) in order to continue as a going concern. Between the reporting date and the date these financial statements were made available, the Group received additional gross funding of approximately US$192 million from the issuance of additional Class A shares and warrants to purchase Class A shares, as well as the triggering of the Additional Funding Amount disclosed in note 21.

There is no certainty that the Group will be successful in obtaining sufficient funding through PDPs, grants, additional private or public offerings of debt and/or equity. If the Group is unsuccessful in raising sufficient capital, the Group’s management will be required to undertake, and is committed to undertaking, additional significant cost-cutting measures including significant headcount reductions that could require us to curtail or discontinue our operations. Such cost-cutting measures should help maintain the liquidity of the Group within the twelve-month period from the issuance date of these interim consolidated financial statements and provide additional time for raising sufficient funds through the start of series production.

Based on its recurring losses from operations since inception, expectation of continuing operating losses in the future and the need to raise additional capital to finance its future operations, which is not assured yet, the Group has concluded that there is substantial doubt about its ability to continue as a going concern, and, therefore, that it may be unable to realize its assets and discharge its liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Despite this substantial doubt, management is continuing to take actions to secure sufficient financing, and thus believes that the application of the going concern assumption for the preparation of these consolidated financial statements is appropriate.

New standards, interpretations and amendments adopted by the Group

The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Group’s audited annual consolidated financial statements for the year ended December 31, 2022, except for the adoption of new standards effective as of January 1, 2023. The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.

Several amendments apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements of the Group.

7

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

3.Significant Accounting Judgments, Estimates and Assumptions

The preparation of the Group’s interim condensed consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts in the interim condensed consolidated financial statements. In preparing these interim condensed consolidated financial statements, management exercises its best judgement based upon its experience and the circumstances prevailing at that time. The estimates and assumptions are based on available information and conditions at the end of the financial period presented and are reviewed on an ongoing basis. Actual results may differ from these estimates under different assumptions and conditions and may materially affect the financial results or the financial position reported in future periods.

Assumptions and estimates relating to the Group’s ability to continue as a going concern are described in note 2.

The Group operates its business as a single operating segment, which is also its reporting segment. An operating segment is defined as a component of an entity for which discrete financial information is available and whose results of operations are regularly reviewed by the chief operating decision maker. The Group’s chief operating decision maker is the Chief Executive Officer, who reviews results of operations to make decisions about allocating resources and assessing performance based on consolidated financial information.

4.Covid-19 Risks and Uncertainties, War in Ukraine and Geopolitical Conflicts

The Board is actively monitoring the impact on the Group from the uncertainty regarding the consequences and lingering impact of the COVID-19 pandemic. The Group had implemented logistical and organizational changes to bolster the Group’s resilience to the COVID-19 pandemic. The extent that COVID-19 continues to impact our business, prospects and results of operations will depend on future developments, which are highly uncertain and cannot be predicted. However, based on the latest developments, the Group expects business operations to continue with minimal to no ongoing impact from the COVID-19 pandemic for the foreseeable future.

The Board is also actively monitoring the impact on the Group from the war in Ukraine. The Group does not and does not intend to have any operations in Ukraine, Belarus or Russia, or engage with direct suppliers located in Ukraine, Belarus or Russia. There is currently no direct impact on the Group from the war in Ukraine and sanctions imposed on Russia and Belarus as the Group does not have any operations or direct suppliers located in these jurisdictions. The Group continues to closely monitor the impact on general economic factors from the war in Ukraine, including the impact of inflation, as such puts pressure on the Group’s costs for employees, raw materials and other parts provided by suppliers.

Finally, the Board is also actively monitoring geopolitical conflicts and tension, including the imposition of and changes in foreign investment, economic sanctions and trade control regulations that could adversely impact our business. There is currently no material impact on the Group’s operations from applicable foreign investment, economic sanctions and trade control regulations. However, the imposition of and changes in such regulations in the future could adversely impact our business.

5.Research and Development Expenses

For the six month period ended June 30, 2023, research and development expenses consisted of €40,003 thousand (June 30, 2022: €38,686 thousand) in personnel expenses, including share-based payment expenses; €24,509 thousand (June 30, 2022: €20,047 thousand) expenses incurred by suppliers on behalf of the Group in preparation for certification and serial production of the Lilium Jet; €6,762 thousand (June 30, 2022: €11,549 thousand) of contractor and consulting expenses; €2,195 thousand (June 30, 2022: €4,594 thousand) in testing component and material costs; €3,912 thousand (June 30, 2022: €2,837 thousand) on amortization and depreciation expenses and €6,914 thousand (June 30, 2022: €5,315 thousand) on other miscellaneous expenses.

8

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

6.General and Administrative Expenses

For the six month period ended June 30, 2023, general and administrative expenses included €16,705 thousand (June 30, 2022: €16,895 thousand) of personnel expenses, including share-based payment expenses; €9,291 thousand (June 30, 2022: €14,921 thousand) of contractor and consulting expenses; €906 thousand success fee in relation to the fundraising activities (June 30, 2022: nil); €8,642 thousand (June 30, 2022: €7,653 thousand) of IT costs including a Cloud Subscription contract (see note 20); €1,667 thousand (June 30, 2022: €3,358 thousand) in insurance premiums primarily related to Directors and Officers’ Liability insurance; and €2,981 thousand (June 30, 2022: €4,160 thousand) of other miscellaneous expenses.

7.Selling Expenses

For the six month period ended June 30, 2023, selling expenses consisted of €3,100 thousand (June 30, 2022: €7,319 thousand) of personnel expenses, including share-based payment expenses, and €1,152 thousand (June 30, 2022: €2,255 thousand) miscellaneous other expenses.

8.Financial Result

Financial result is comprised of the following for the six month periods ended June 30, 2023 and 2022:

In € thousand

    

June 30, 2023

    

June 30, 2022

Finance income

3,021

16,597

thereof: fair value changes

 

 

17,369

thereof: foreign currency exchange gains / (losses) on financial instruments

1,542

(1,019)

thereof: reversal of expected credit losses

 

 

124

thereof: other interest income

1,479

Finance expenses

 

(258,739)

 

(931)

thereof: fair value changes

 

(258,337)

 

(67)

thereof: interest portion of lease payments

 

(292)

 

(230)

thereof: expected credit losses

 

(29)

 

(87)

thereof: other interest expenses

 

(81)

 

Financial result

 

(255,718)

 

15,666

Finance income in the current period resulted from foreign currency gain on warrant liabilities of €1,542 thousand (June 30, 2022: €1,019 thousand foreign currency expense) and other interest income of €1,479 thousand (June 30, 2022: nil) relating to interest on fixed-term deposits and cash at bank.

Finance expenses in the current period mainly resulted from the fair value changes of the warrant revaluation of €258,337 thousand (June 30, 2022: €17,369 thousand gain in finance income). For further information please refer to note 17.

9.Income Taxes

The Group calculated the period income tax expense, during the six month period ended June 30, 2023 for which the Group recorded consolidated income tax expense of €83 thousand (June 30, 2022: income tax benefit of €478 thousand). These income taxes mainly relate to foreign subsidiaries.

Major deferred income taxes have not been recorded. The netting of deferred tax liabilities and deferred tax assets results in a net deferred tax asset. The net deferred tax asset has been valued at zero. Deferred tax assets on the tax losses carried forward are not recognized either given the tax losses carried forward relate to entities with a history of losses.

9

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

10.Property, Plant and Equipment

During the six month period ended June 30, 2023, the Group acquired assets with a cost of €11,476 thousand (June 30, 2022: €4,320 thousand):

In € thousand

    

June 30, 2023

    

December 31, 2022

Right to land and buildings and leasehold improvements

15,737

13,807

Vehicles

87

87

Technical equipment and machinery

 

16,815

 

15,643

Office and other equipment

 

3,533

 

4,275

Assets under construction

 

8,684

 

2,887

Carrying amount

 

44,856

 

36,699

No indicators of impairment were identified which would have required items of property, plant and equipment to be tested for impairment in the six month periods ended June 30, 2023 and 2022.

11.Investment in a Joint Venture

Investment in Ionblox

The movement in the investment in Ionblox, Inc (“Ionblox”) during the period was as follows:

In € thousand

    

Carrying Value

January 1, 2023

13,410

Share of loss in a joint venture

 

(1,165)

June 30, 2023

 

12,245

12.Other Financial Assets

Other financial assets are as follows:

In € thousand

    

June 30, 2023

    

December 31, 2022

Security deposits

 

3,451

 

3,386

Total non-current financial assets

 

3,451

 

3,386

Fixed term deposits

 

60,094

 

19,987

Security deposits

 

109

 

2,594

Total current other financial assets

 

60,203

 

22,581

Lilium has placed part of its liquidity in fixed term deposits with a remaining term of more than 3 months to gain a better return on the surplus liquidity. During the period ended June 30, 2023, €20,139 thousand (June 30, 2022: €79,849 thousand) cash was received from matured deposits. The Group invested €60,000 thousand into new fixed-term deposits (December 31, 2022: €20,000 thousand). There was €338 thousand recognized from interest income (June 30, 2022: €359 thousand interest expense), while there was an increase in Expected Credit Losses of €92 thousand (June 30, 2022: decrease of €105 thousand). As of June 30, 2023, the Group held €60,094 thousand (December 31, 2022: €19,987 thousand) in fixed-term deposits.

10

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

13.Non-Financial Assets

Non-financial assets are as follows:

In € thousand

    

June 30, 2023

    

December 31, 2022

Advance payments

12,370

4,069

Prepaid expenses

4,818

9,418

Total non-current non-financial assets

 

17,188

 

13,487

Value added tax claims

 

2,254

 

1,696

Prepaid expenses

 

7,161

 

16,241

Miscellaneous other current non-financial assets

 

468

 

711

Total current non-financial assets

 

9,883

 

18,648

Total non-financial assets

 

27,071

 

32,135

14.Shareholders’ (deficit) / equity

The movements of the shares issued during the six month periods ended June 30, 2023 and 2022, are as follows:

Common

Supervoting

Ordinary

shares

shares

shares

(in units)

    

(Class A)

    

(Class B)

    

(Class C)

    

Total

Issued at January 1, 2023

 

369,820,821

 

23,888,065

 

525,000

 

394,233,886

Issued shares for share-based payments exercised

 

10,585,912

 

 

 

10,585,912

Conversion of Class B Shares

350,000

(350,000)

350,000

350,000

Cancellation of issued shares

 

 

(425,000)

 

(105,000)

 

(530,000)

Issued as of June 30, 2023

380,756,733

23,113,065

770,000

404,639,798

Treasury shares

(770,000)

(770,000)

Outstanding as of June 30, 2023

 

380,756,733

 

23,113,065

 

 

403,869,798

Common

Supervoting

Ordinary

shares

shares

shares

(in units)

    

(Class A)

    

(Class B)

    

(Class C)

    

Total

Issued at January 1, 2022

 

261,244,915

 

24,413,065

 

 

285,657,980

Issued shares for share-based payments exercised

 

8,392,206

 

 

 

8,392,206

Warrants exercised

 

10

 

 

 

10

ELOC commitment shares

 

262,697

 

 

 

262,697

Issued as of June 30, 2022

 

269,899,828

 

24,413,065

 

 

294,312,893

Treasury shares

(375,000)

(375,000)

Treasury shares (due to consolidation)

(879,691)

(879,691)

Outstanding as of June 30, 2022

 

268,645,137

 

24,413,065

 

 

293,068,202

During the six month period ended June 30, 2023, in total 10,585,912 shares (June 30, 2022: 8,392,206 shares) have been issued due to the execution of vested share-based payments; €1,270 thousand (June 30, 2022: €1,007 thousand) have been added to subscribed capital, thereof €1,117 thousand (June 30, 2022: €990 thousand) are transferred from other capital reserves.

During the six month period ended June 30, 2023, €82,829 thousand is recognized in other capital reserves in relation to the May 2023 Warrants derivative financial instrument, as described in note 17 and note 20.

11

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Cancellation of issued shares

During the period the Group cancelled 425,000 of Lilium N.V.'s Class B ordinary shares ("Class B Shares") and 105,000 of Lilium N.V.'s Class C ordinary shares ("Class C Shares") held in treasury, resulting in a reduction in subscribed capital and corresponding reduction in treasury shares of €178 thousand.

Conversion of Class B Shares

During February 2023, a shareholder who is an executive director and a member of key management personnel of Lilium N.V. converted 350,000 Class B Shares into 350,000 Class A Shares and 350,000 Class C shares and transferred the Class C shares back to the Group as treasury shares for no consideration pursuant to Lilium N.V.'s articles of association, increasing the treasury share reserve by €84 thousand.

Treasury shares

The reserve for treasury shares represents the nominal amount of Lilium N.V.’s own shares held in treasury. Payments for treasury shares above or below nominal value are deducted from or added to share premium, respectively. The movement of treasury shares during periods are as follows:

    

Common

    

Supervoting

    

Ordinary

    

shares

shares

shares

(in units)

(Class A)

(Class B)

(Class C)

Total

At January 1, 2023

 

 

425,000

 

525,000

 

950,000

Conversion of Class B shares

 

 

 

350,000

 

350,000

Cancellation of Class B shares

 

 

(425,000)

 

(105,000)

 

(530,000)

At June 30, 2023

 

 

 

770,000

 

770,000

    

Common

    

Supervoting

    

Ordinary

    

shares

shares

shares

(in units)

(Class A)

(Class B)

(Class C)

Total

At January 1, 2022 and June 30, 2022

 

1,254,691

 

 

 

1,254,691

12

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

15.Share-based Payments

Overview

Lilium offers several share-based plans as summarized in the table below.

The table below summarizes the expense/(income) recorded for share-based payments in the six month periods ended June 30, 2023 and 2022:

In € thousand

    

June 30, 2023

    

June 30, 2022

Equity-settled

General population and executives – standard ESOP

 

3,684

 

5,225

General population – Restricted Stock Units (“RSU”)

 

2,312

 

1,728

Executives – ESOP modified

 

504

 

1,705

Executives – RSU

 

1,845

 

1,676

Executives – Performance-based stock options

 

1,058

 

(919)

Executives – Time-based stock options

 

553

 

3,463

Share-based payment – Vendor

4,561

Cash-settled

Joint stock ownership Plan (JSOP) incl. bonus

 

 

(3,411)

Executives – Success fees

2,141

Total expense

 

14,517

 

11,608

General population and Executives - standard Employee Stock Option Program (“ESOP”)

The expense recognized for participant services received during the six month periods ended June 30, 2023 and 2022 is shown in the following table:

In € thousand

    

June 30, 2023

    

June 30, 2022

Expense arising from equity-settled share-based payments

 

3,684

 

5,225

There were no options granted during the current period (June 30, 2022: Fair value of options granted during the period was €17,483 thousand). The exact weighted average exercise prices (“WAEP”) for all options is €1 for 2,857 shares, which is 0.00035 and rounded to nil. The Group waived the employees’ liability for the share capital.

Movements during the period

The following table illustrates the number and WAEP of, and movements in, such Lilium N.V. share options during the six month periods ended June 30, 2023 and 2022:

Equity-settled options:

2023

2022

Number

2023

Number

2022

(in units)

    

of options

    

WAEP

    

of options

    

WAEP

Outstanding at January 1

 

8,049,568

0.00

 

19,573,307

0.00

Granted during the period

 

0.00

 

5,714

0.00

Forfeited during the period

 

(445,963)

0.00

 

(442,835)

0.00

Exercised during the period

 

(1,278,108)

0.00

 

(8,253,725)

0.00

Transferred to cash-settled

 

0.00

 

(22,856)

0.00

Outstanding at June 30

 

6,325,497

0.00

 

10,859,605

0.00

13

Table of Contents

Lilium Group

IFRS INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Cash-settled options:

    

2023

    

2023

    

2022

    

2022

(in units)

Number of options

WAEP

Number of options

WAEP

Outstanding at January 1 and June 30

 

5,714

0.00

 

22,856

0.00

The weighted average remaining contractual life is 10.2 years for equity-settled options and 10.0 years for cash-settled options.

Total options that vested during the period were 355,912 options (June 30, 2022: 1,545,389 options). The weighted average share price for exercised options has been €1.09 (June 30, 2022: €3.77).

As of June 30, 2023, 6,026,558 options (December 31, 2022: 7,043,620 options) are vested and are exercisable at the request of the employee with a WAEP of €0.00 (December 31, 2022: €0.00).

General population - Restricted Stock Units

The expense recognized for participant services received during the six month periods ended June 30, 2023 and 2022 is shown in the following table:

In € thousand

    

June 30, 2023

    

June 30, 2022

Expense arising from equity settled RSU

 

2,312

 

1,728

Movements during the periods

The following table illustrates the number and WAEP of, and movements in, such RSUs during the six month periods ended June 30, 2023 and 2022:

2023

2022

Number

2023

Number

2022

(in units)

    

of RSUs

    

WAEP

    

of RSUs

    

WAEP

Outstanding at January 1

 

4,275,098

0.12

 

162,800

 

0.12

Assigned during the period

 

1,790,364

0.12

 

2,782,614

 

0.12

Exercised during the period

(1,017,273)

0.12

Forfeited during the period